Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.
18. April 2019 13:08 ET
|
Generex Biotechnology Corp.
Inventor Dr. Lois Chandler, PhD Presents Excellagen® Clinical Trial Data Demonstrating Rapid Healing of Diabetic Neuropathic Foot Ulcers MIRAMAR, FL, April 18, 2019 (GLOBE NEWSWIRE) -- via...
Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors
08. April 2019 09:00 ET
|
Generex Biotechnology Corp.
Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing MIRAMAR, FL, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology...
Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing
04. April 2019 15:35 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex would like to clarify the discussions surrounding the filed 10-Q ending the period of January 31, 2019, or the second...
Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
29. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL,...
Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting
26. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Excellagen Clinical Trial Analysis: Rapid Healing of Diabetic Neuropathic Foot Ulcers Presentation on Friday Evening April 5, 2019 at the JW Marriott Hotel in Washington, DC MIRAMAR, FL,...
Generex Biotechnology Announces the Appointment of Chief Commercial Officer
12. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Lance Goudzwaard Appointed to Head Commercialization and Customer Relations for NuGenerex Distribution Solutions Subsidiary MIRAMAR, FL, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy
08. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Industry Veteran John P. Sentman to Lead Strategic Sales and Partnering MIRAMAR, FL, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Olaregen Therapeutix, a subsidiary of Generex...
Generex Investor Conference Call Now Available Online
01. März 2019 09:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details
26. Februar 2019 08:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)
19. Februar 2019 09:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to...